Breast cancer encompasses multiple subtypes, including luminal A, luminal B, HER2-enriched, and triple-negative breast cancer, each with distinct molecular characteristics and clinical behaviors [26]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.